Office of Research & Development |
|
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01CX001441-01A1 |
| Title: | Role of SIRT3 in melanoma development and progression |
| Principal Investigator: | Nihal Ahmad |
| Location: | Madison, WI |
| Congressional District Code: | 2 |
| Research Service: | Clinical Science R&D |
| Project Period: | April 2017 - December 2021 |
| FY 2021 Funding Amount: | $82,500 |
| Total Award Amount (all years): |
$747,500 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Melanoma, one of the deadliest cancer of skin, arises from melanocytic cells that are responsible for melanin production. Recent advances in the understanding of melanoma biology has led to the development of targeted therapies with promise. For example, BRAF inhibitors vemurafenib and dabrafenib achieved significant improvement over chemotherapy and were approved for metastatic melanomas with BRAF- mutations. More recently, the combination of dabrafenib with MEK inhibitor trametinib demonstrate... |